Skip to content

Drug interactions

Lonafarnib + Topotecan

Severity: Minor

Lonafarnib and Topotecan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a weak P-gp inhibitor and may modestly raise levels of P-gp substrates such as topotecan. The effect is probably small but could matter for a narrow-margin cytotoxic drug.

What this interaction means in plain words

Lonafarnib and Topotecan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lonafarnib belongs to Miscellaneous; Topotecan belongs to Oncology.

Evidence level: Low

Why it happens

Weak P-glycoprotein inhibition by lonafarnib reduces topotecan efflux.

What to do

Monitor blood counts as routine for topotecan and reduce the dose if unexpected toxicity occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lonafarnib and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lonafarnib with Topotecan?

MediHelp rates the interaction as minor. Lonafarnib and Topotecan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lonafarnib is a weak P-gp inhibitor and may modestly raise levels of P-gp substrates such as topotecan. The effect is probably small but could matter for a narrow-margin cytotoxic drug.

How serious is the interaction between Lonafarnib and Topotecan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts as routine for topotecan and reduce the dose if unexpected toxicity occurs.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in